Table 1. Association of AIB1 amplification with clinicopathologic characteristics in gastric cancers.
Variables | AIB1 amplification (n = 133) | ||
---|---|---|---|
Yes | No | P | |
No. of patients | 47 | 86 | |
Gender | |||
Male | 67 | 37 | 0.91 |
Female | 19 | 10 | |
Age, years | |||
Mean ± SD | 62.68 ±13.83 | 57.38 ±12.33 | 0.003 |
≤ 50 | 9 | 25 | |
50–60 | 4 | 26 | |
60–70 | 21 | 25 | |
> 70 | 13 | 10 | |
Tumor localization | |||
gastric cardia | 16 | 20 | 0.41 |
gastric body | 10 | 25 | |
gastric antrum | 21 | 41 | |
Tumor size (cm3) | |||
≤ 3 | 10 | 33 | 0.12 |
3–5 | 20 | 27 | |
> 5 | 17 | 26 | |
Differentiation | |||
well/moderate | 14 | 43 | 0.03 |
poor/undifferentiation | 33 | 43 | |
Tumor invasion | |||
T1/T2 | 8 | 29 | 0.04 |
T3/T4 | 39 | 57 | |
TNM stage | |||
I | 6 | 25 | 0.08 |
II | 8 | 13 | |
III | 31 | 44 | |
IV | 2 | 4 | |
Lymph node metastasis | |||
Yes | 32 | 49 | 0.21 |
No | 15 | 37 | |
Survival status | |||
Dead | 31 | 35 | 0.006 |
Alive | 16 | 51 |